Full View

N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs–an updated review

Y Zhang, Y Xu, Y Bao, Y Luo, G Qiu, M He, J Lu, J Xu… - Epigenetics, 2023 - Taylor & Francis
Osteosarcoma, originating from primitive bone-forming mesenchymal cells, is the most
common malignant bone tumour among children and adolescents. N6-methyladenosine …
被引用次数：3 相关文章
[HTML] nih.gov

[HTML][HTML] N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs–an updated review

Y Zhang, Y Xu, Y Bao, Y Luo, G Qiu, M He, J Lu, J Xu… - Epigenetics, 2023 - ncbi.nlm.nih.gov
Osteosarcoma, originating from primitive bone-forming mesenchymal cells, is the most
common malignant bone tumour among children and adolescents. N6-methyladenosine …

N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs-an updated review

Y Zhang, Y Xu, Y Bao, Y Luo, G Qiu, M He… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Osteosarcoma, originating from primitive bone-forming mesenchymal cells, is the most
common malignant bone tumour among children and adolescents. N6-methyladenosine …

N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs-an updated review.

Y Zhang, Y Xu, Y Bao, Y Luo, G Qiu, M He, J Lu, J Xu… - Epigenetics, 2023 - europepmc.org
Osteosarcoma, originating from primitive bone-forming mesenchymal cells, is the most
common malignant bone tumour among children and adolescents. N6-methyladenosine …

N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs-an updated review.

Y Zhang, Y Xu, Y Bao, Y Luo, G Qiu, M He, J Lu, J Xu… - Epigenetics, 2023 - europepmc.org
Osteosarcoma, originating from primitive bone-forming mesenchymal cells, is the most
common malignant bone tumour among children and adolescents. N6-methyladenosine …